3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
34
Ovarian Neoplasms
7
Neoplasm Metastasis
6
Endometrial Neoplasms
6
Uterine Cervical Neoplasms
4
Triple Negative Breast Neoplasms
4
Prostatic Neoplasms
4
Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Neoplasms by Site
3
Breast Diseases
3
Advanced Breast Cancer
3
Small Cell Lung Carcinoma
2
Melanoma
2
Hereditary Sensory and Autonomic Neuropathies
2
Head and Neck Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Unilateral Breast Neoplasms
1
Stomach Neoplasms
1
Spinocerebellar Degenerations
1
Recurrence
1
Locally Advanced (Inoperable) or Metastatic Breast Cancer
1
Genital Neoplasms, Female
1
Genetic Diseases, Inborn
1
Fallopian Tube Neoplasms
1
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
1
Interventions
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
taxane
1
radium Ra 223 dichloride
1
pertuzumab
1
X-Rays
1
Trastuzumab
1
Taxoids
1
Taxes
1
Steroids
1
Radiotherapy
1
Radiosurgery
1
Radiation
1
Photons
1
Paclitaxel
1
PF-05280014
1
Ontruzant
1
Ogivri
1
Mastectomy, Simple
1
Mastectomy, Segmental
1
Hormones
1
High-Energy Shock Waves
1
Cyclin-Dependent Kinase Inhibitor p18
1
Cyclin-Dependent Kinase Inhibitor p16
1
CT-P6
1
Biopsy
1
Ado-Trastuzumab Emtansine
1
2C4 antibody
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anatomic Stage IV Breast Cancer AJCC v8
×
Fulvestrant
×
30 days
×
Clear all
No trials found.